Cancer test maker Grail said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.
Cancer test maker Grail said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer.
